These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22363291)

  • 1. Biological Significance of Local TGF-β Activation in Liver Diseases.
    Hayashi H; Sakai T
    Front Physiol; 2012; 3():12. PubMed ID: 22363291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor β latency: A mechanism of cytokine storage and signalling regulation in liver homeostasis and disease.
    Li Y; Fan W; Link F; Wang S; Dooley S
    JHEP Rep; 2022 Feb; 4(2):100397. PubMed ID: 35059619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic liver injury, TGF-beta, and cancer.
    Bissell DM
    Exp Mol Med; 2001 Dec; 33(4):179-90. PubMed ID: 11795478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-β1 and PDGF.
    Atorrasagasti C; Aquino JB; Hofman L; Alaniz L; Malvicini M; Garcia M; Benedetti L; Friedman SL; Podhajcer O; Mazzolini G
    Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G739-48. PubMed ID: 21311029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L(59) TGF-β LAP degradation products serve as a promising blood biomarker for liver fibrogenesis in mice.
    Hara M; Inoue I; Yamazaki Y; Kirita A; Matsuura T; Friedman SL; Rifkin DB; Kojima S
    Fibrogenesis Tissue Repair; 2015; 8():17. PubMed ID: 26379781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction.
    Kwiecinski M; Noetel A; Elfimova N; Trebicka J; Schievenbusch S; Strack I; Molnar L; von Brandenstein M; Töx U; Nischt R; Coutelle O; Dienes HP; Odenthal M
    PLoS One; 2011; 6(9):e24568. PubMed ID: 21931759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanism Responsible for Fibronectin-controlled Alterations in Matrix Stiffness in Advanced Chronic Liver Fibrogenesis.
    Iwasaki A; Sakai K; Moriya K; Sasaki T; Keene DR; Akhtar R; Miyazono T; Yasumura S; Watanabe M; Morishita S; Sakai T
    J Biol Chem; 2016 Jan; 291(1):72-88. PubMed ID: 26553870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor.
    Zheng S; Chen A
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G883-93. PubMed ID: 16306131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats.
    Marquez-Aguirre A; Sandoval-Rodriguez A; Gonzalez-Cuevas J; Bueno-Topete M; Navarro-Partida J; Arellano-Olivera I; Lucano-Landeros S; Armendariz-Borunda J
    J Gene Med; 2009 Mar; 11(3):207-19. PubMed ID: 19189315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibronectin protects from excessive liver fibrosis by modulating the availability of and responsiveness of stellate cells to active TGF-β.
    Kawelke N; Vasel M; Sens C; Au Av; Dooley S; Nakchbandi IA
    PLoS One; 2011; 6(11):e28181. PubMed ID: 22140539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
    Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
    Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombospondin-1 is a novel negative regulator of liver regeneration after partial hepatectomy through transforming growth factor-beta1 activation in mice.
    Hayashi H; Sakai K; Baba H; Sakai T
    Hepatology; 2012 May; 55(5):1562-73. PubMed ID: 22105716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis.
    Kim J; Kang W; Kang SH; Park SH; Kim JY; Yang S; Ha SY; Paik YH
    Sci Rep; 2020 Dec; 10(1):21018. PubMed ID: 33273492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrins modulate cellular fibrogenesis at multiple levels; Regulation of TGF-β signaling.
    Hayashida T
    Endocr Metab Immune Disord Drug Targets; 2010 Dec; 10(4):302-19. PubMed ID: 20925652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neovessel formation promotes liver fibrosis via providing latent transforming growth factor-β.
    Sakata K; Eda S; Lee ES; Hara M; Imoto M; Kojima S
    Biochem Biophys Res Commun; 2014 Jan; 443(3):950-6. PubMed ID: 24361885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-TGF-beta strategies for the treatment of chronic liver disease.
    Breitkopf K; Haas S; Wiercinska E; Singer MV; Dooley S
    Alcohol Clin Exp Res; 2005 Nov; 29(11 Suppl):121S-131S. PubMed ID: 16344596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation.
    Verrecchia F; Mauviel A
    J Invest Dermatol; 2002 Feb; 118(2):211-5. PubMed ID: 11841535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of TGF-β1-Induced Pro-Apoptotic Signaling by Growth Factor Receptors and Extracellular Matrix Receptor Integrins in the Liver.
    Ozaki I; Hamajima H; Matsuhashi S; Mizuta T
    Front Physiol; 2011; 2():78. PubMed ID: 22028694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis.
    Shek FW; Benyon RC; Walker FM; McCrudden PR; Pender SL; Williams EJ; Johnson PA; Johnson CD; Bateman AC; Fine DR; Iredale JP
    Am J Pathol; 2002 May; 160(5):1787-98. PubMed ID: 12000730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.